| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.
|
Blood
|
1989
|
2.02
|
|
2
|
Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.
|
Ann Hematol
|
1999
|
1.02
|
|
3
|
Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.
|
Exp Hematol
|
1997
|
0.97
|
|
4
|
A comprehensive leukemia database: integration of cytogenetics, molecular genetics and microarray data with clinical information, cytomorphology and immunophenotyping.
|
Leukemia
|
2001
|
0.91
|
|
5
|
Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells.
|
Br J Haematol
|
1996
|
0.89
|
|
6
|
Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.
|
Eur J Immunol
|
1996
|
0.83
|
|
7
|
Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro.
|
Cancer Chemother Pharmacol
|
1990
|
0.81
|
|
8
|
Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeks.
|
Invest New Drugs
|
1988
|
0.80
|
|
9
|
Interleukin 1 modulates growth of human renal carcinoma cells in vitro.
|
Br J Cancer
|
1995
|
0.80
|
|
10
|
Therapeutic activity of 1-beta-D-arabinofuranosylcytosine conjugates of lipids in WEHI-3B leukemia in mice.
|
Exp Hematol
|
1989
|
0.79
|
|
11
|
Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agents.
|
Eur J Cancer
|
1993
|
0.78
|
|
12
|
Effects of hematopoietic growth factors on malignant nonhematopoietic cells.
|
Semin Oncol
|
1992
|
0.78
|
|
13
|
Antitumoral activity of a xanthate compound. I. Cytotoxicity studies with neoplastic cell lines in vitro.
|
Cancer Lett
|
1989
|
0.76
|
|
14
|
Antitumoral activity of a xanthate compound. II. Therapeutic studies in murine leukemia and tumor models in vivo.
|
Cancer Lett
|
1989
|
0.76
|
|
15
|
Stimulation of clonal growth of human colorectal tumor cells by IL-3 and GM-CSF. Modulation of 5-FU cytotoxicity by GM-CSF.
|
Onkologie
|
1990
|
0.75
|
|
16
|
Effects of recombinant human erythropoietin on clonogenic growth of primary human tumour specimens in vitro.
|
Eur J Cancer
|
1992
|
0.75
|
|
17
|
Two uncommon lymphomas. Case 1: abdominal Burkitt's lymphoma.
|
J Clin Oncol
|
1999
|
0.75
|
|
18
|
The activation of intracellular tyrosine kinases by interferon-alpha (IFNalpha) correlates with its antiproliferative activity in B-lymphoid cell lines, but not in B-cell chronic lymphocytic leukemia patients.
|
Ann Hematol
|
2000
|
0.75
|
|
19
|
Lack of therapeutic effects of platelet activating factor antagonists in WEHI-3B leukemia, human xenotransplanted colorectal and lung cancer and Lewis-lung tumor in vivo.
|
Cancer Lett
|
1992
|
0.75
|